Tech Company Financing Transactions
BIND Therapeutics Funding Round
Private investors participated in a $1.4 million Series C capital raise for BIND Therapeutics. The round was announced on 6/29/2010.
Transaction Overview
Company Name
Announced On
6/29/2010
Transaction Type
Venture Equity
Amount
$1,400,000
Round
Series C
Investors
Proceeds Purpose
The company plans to use some of the new funding to usher its first drug-loaded nanoparticle into a Phase I clinical study for treating solid tumors.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
325 Vassar St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
BIND Therapeutics is a venture backed biopharmaceutical company focused on engineering targeted therapeutics. BIND's technology was developed by world class laboratories at MIT and Harvard.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrew Hirsch
Chief Medical Officer
Hagop Youssoufian
VP - Bus. Development
Daniel Koerwer
VP - Bus. Development
Stephen Zale
VP - Finance
Chris Lindblom
VP - Regulatory Affairs
David Mantus
Browse more venture capital transactions:
Prev: 6/28/2010: Envirogen Technologies venture capital transaction
Next: 6/29/2010: Pervacio venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs